Autologous Dendritic Cells in Combination With Chemotherapy Restore Responsiveness of T Cells in Breast Cancer Patients: A Single-Arm Phase I/II Trial

Autologous Dendritic Cells in Combination With Chemotherapy Restore Responsiveness of T Cells in Breast Cancer Patients: A Single-Arm Phase I/II Trial

IntroductionAnimal studies and preclinical studies in cancer patients suggest that the induction of immunogenic cell death (ICD) by neoadjuvant chemotherapy with doxorubicin and cyclophosphamide (NAC-AC) recovers the functional performance of the immune system. This could favor immunotherapy schemes...

Full description

Bibliographic Details
Main Authors:	David A. Bernal-Estévez, Mauren A. Ortíz Barbosa, Paola Ortíz-Montero, Claudia Cifuentes, Ramiro Sánchez, Carlos A. Parra-López
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-08-01
Series:	Frontiers in Immunology
Subjects:	breast cancer immunotherapy dendritic cells neoadjuvant chemotherapy clinical trial
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.669965/full

Similar Items

Monitoring the responsiveness of T and antigen presenting cell compartments in breast cancer patients is useful to predict clinical tumor response to neoadjuvant chemotherapy
by: David A. Bernal-Estévez, et al.
Published: (2018-01-01)

Rationale for a multimodality strategy to enhance the efficacy of dendritic cell-based cancer immunotherapy
by: Jashodeep eDatta, et al.
Published: (2015-06-01)

Autologous Dendritic Cell Vaccine Optimization for Therapy of Patients with Disseminated Malignant Ne
by: T. L. Nehaeva
Published: (2016-02-01)

Neoadjuvant and Adjuvant Chemotherapy in Osteosarcoma (The Experience of HORC in the Shariati Hospital)
by: Alimoghadam K, et al.
Published: (2004-07-01)

Neoadjuvant immunotherapy combined with chemotherapy for locally advanced squamous cell lung carcinoma: A case report and literature review
by: Zheng Yuan, et al.
Published: (2021-08-01)

First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
by: Linda M. Liau, et al.
Published: (2018-05-01)

Autologous dendritic cells pulsed with allogeneic tumour cell lysate induce tumour-reactive T-cell responses in patients with pancreatic cancer: A phase I study
by: Aerts, J.G, et al.
Published: (2022)

Survival gain in glioblastoma patients treated with dendritic cell immunotherapy is associated with increased NK but not CD8+ T cell activation in the presence of adjuvant temozolomide
by: Serena Pellegatta, et al.
Published: (2018-04-01)

History and current situation of neoadjuvant treatment for locally advanced esophageal cancer
by: Junyi Li, et al.
Published: (2021-09-01)

Neoadjuvant and Adjuvant Chemotherapy in Osteosarcoma (The Experience of HORC in the Shariati Hospital)
by: K Alimoghadam, et al.
Published: (2004-03-01)

Metronomic Chemotherapy Combined with Dendritic Cell Vaccine  Inhibits VEGF Secretion
by: Yan ZHOU, et al.
Published: (2013-09-01)

Clinical impact of T cells, B cells and the PD-1/PD-L1 pathway in muscle invasive bladder cancer: a comparative study of transurethral resection and cystectomy specimens
by: Sara Wahlin, et al.
Published: (2019-11-01)

A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients
by: Susana Inogés, et al.
Published: (2017-05-01)

Short-course radiation followed by mFOLFOX-6 plus avelumab for locally-advanced rectal adenocarcinoma
by: Ali Shamseddine, et al.
Published: (2020-09-01)

Dendritic Cells in Anticancer Vaccination: Rationale for Ex Vivo Loading or In Vivo Targeting
by: Alexey V. Baldin, et al.
Published: (2020-03-01)

Immunotherapy of patients with multiple and extreme drug-resistant pulmonary tuberculosis with autologous monocyte- and stem cell-derived dendritic cells vaccine
by: L P Titov, et al.
Published: (2015-01-01)

Adjuvant immunotherapy with autologous dendritic cells for hepatocellular carcinoma, randomized phase II study
by: Jeong-Hoon Lee, et al.
Published: (2017-07-01)

Short-term Outcomes in Patients with Carcinoma of the Esophagus and Gastroesophageal Junction Receiving Neoadjuvant Chemotherapy or Chemoradiation before Surgery. A Prospective Study
by: Syed Nusrath, et al.
Published: (2019-01-01)

The main markers of the long-term efficiency of neoadjuvant chemotherapy in breast cancer (review of literature)
by: V F Semiglazov, et al.
Published: (2013-12-01)

Potential immune priming of the tumor microenvironment with FOLFOX chemotherapy in locally advanced rectal cancer
by: Campbell S. Roxburgh, et al.
Published: (2018-06-01)

Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced oesophageal squamous cell carcinoma: a single-Centre, open-label, randomized, controlled, clinical trial (HCHTOG1903)
by: Hai-Bo Sun, et al.
Published: (2020-04-01)

Neoadjuvant or adjuvant chemotherapy: what is the best treatment of muscle invasive bladder cancer?
by: Nabil Ismaili, et al.
Published: (2011-09-01)

Optimal Timing of Surgery after Neoadjuvant Chemotherapy of Breast Cancer
by: Borna Farazmand, et al.
Published: (2017-03-01)

Neoadjuvant chemotherapy for primary sarcoma of the breast: a case report
by: Chieko Miyazaki, et al.
Published: (2019-09-01)

Preliminary Efficacy Evaluation of Neoadjuvant Immunotherapy Combined with  Chemotherapy in Resectable Non-small Cell Lung Cancer
by: Shijie ZHOU, et al.
Published: (2021-06-01)

Immune Response Generated With the Administration of Autologous Dendritic Cells Pulsed With an Allogenic Tumoral Cell-Lines Lysate in Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma
by: Daniel Benitez-Ribas, et al.
Published: (2018-04-01)

High-risk bladder cancer: improving outcomes with perioperative chemotherapy
by: Daniel Y.C. Heng, et al.
Published: (2011-12-01)

High-risk bladder cancer: improving outcomes with perioperative chemotherapy
by: Daniel Y.C. Heng, et al.
Published: (2011-12-01)

Application of Neoadjuvant Immuno-chemotherapy in NSCLC
by: Si CHEN, et al.
Published: (2021-04-01)

Effect of preoperative paclitaxel + cisplatin neoadjuvant chemotherapy on the proliferation and invasion of cancer cells in esophageal cancer
by: Cong-Hua Chen
Published: (2018-04-01)

Dendritic Cells and T Cells, Partners in Atherogenesis and the Translating Road Ahead
by: Li Sun, et al.
Published: (2020-07-01)

Dendritic Cell-Induced Th1 and Th17 Cell Differentiation for Cancer Therapy
by: Julia Terhune, et al.
Published: (2013-11-01)

Corrigendum: Immune Response Generated With the Administration of Autologous Dendritic Cells Pulsed With an Allogenic Tumoral Cell-Lines Lysate in Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma
by: Daniel Benitez-Ribas, et al.
Published: (2018-06-01)

Outcomes of neoadjuvant chemotherapy in resectable, borderline resectable and locally advanced pancreatic cancer
by: Kamil D. Dalgatov, et al.
Published: (2021-08-01)

The incidence of free peritoneal tumor cells before and after neoadjuvant chemotherapy in gastroesophageal junction cancer
by: Rune B Strandby, et al.
Published: (2020-01-01)

Neoadjuvant chemotherapy in neonatal Wilms′ tumor
by: Ramesh K Reddy, et al.
Published: (2015-01-01)

Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial
by: Piperno Sophie, et al.
Published: (2005-03-01)

Significance of circulating tumor cells in osteosarcoma patients treated by neoadjuvant chemotherapy and surgery
by: Wu ZJ, et al.
Published: (2018-09-01)

Impact of various options of neoadjuvant chemotherapy on the hormonal status of patients with breast cancer
by: Yu. S. Sidorenko, et al.
Published: (2014-08-01)

Neoadjuvant chemotherapy in the treatment of rectal cancer without mesorectal fascia involvement but with negative prognostic factors
by: S. O. Kochkina, et al.
Published: (2020-08-01)